Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.

How Eli Lilly Got Huge by Making Us Thin
31:22

Cyberbullying Group 764 Torments Teenagers as Blood Sport
28:19

Caveat Injector
36:42